跳至主要内容
临床试验/NCT05283382
NCT05283382招募中早期 1 期

Cannabidiol Effects on Learning and Anxiety

University of Connecticut2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
入组人数
160
试验地点
2
主要终点
Electrodermal activity

研究概览

简要总结

To examine the extent to which Cannabidiol (CBD) enhances fear conditioning extinction in college undergraduates who show elevated social anxiety. Undergraduates who display elevated social anxiety on standard assessments will be recruited at the University of Connecticut. All participants will be put in a standard fear conditioning paradigm where they are conditioned to fear a face that occasionally is followed by a shock to their wrist. The other face never is paired with a shock. After everybody learns this, half of the participants will receive 600 mg CBD Isolate Gel Capsules one time, and the other half will receive a placebo dose. Participants will then be presented with the faces with no shocks, and the rate and duration of extinction as measured by electrodermal response as well as subjective fear ratings via a visual analogue scale will be examined. It is hypothesized that participants that receive CBD will display enhanced extinction compared to the placebo group, as evidenced by reduced electrodermal response and reduced visual analogue fear ratings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Double (Participant, Investigator)

盲法说明

double blind

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-50 years of age

排除标准

  • Difficulties seeing a computer screen
  • Anyone currently taking CBD within the last 24 hours.
  • Anyone using any cannabis product within the last 24 hours.
  • Heart problems or heart disease
  • A neurological disorder such as epilepsy, stroke, multiple sclerosis, tumor, vascular malformations, aneurysm
  • Are currently pregnant or breast-feeding

研究组 & 干预措施

Cannabidiol

Experimental

600 mg Cannabidiol Isolate Gel Capsules / participant. One-time dose.

干预措施: Cannabidiol Oral Product (Drug)

Placebo

Placebo Comparator

Same number of placebo capsules / participant. One-time dose.

干预措施: Placebo (Other)

结局指标

主要结局

Electrodermal activity

时间窗: 20 minutes

Electrodermal response as measured by galvanic skin response electrodes that are attached to two of the fingers via sticker electrodes. These passively measure the conductance of the sweat glands on the fingers.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Astur

Associate Professor

University of Connecticut

研究点 (2)

Loading locations...

相似试验